Several resistant mutants thus obtained were shown to have mutated from Lac-to Lac+. This simultaneous mutation in the lac gene may be related to the map position of this additional locus for kasugamycin resistance in consideration of the nature of the mutagen used. One of the kasugamycin resistance mutations was found to be associated with the alteration of ribosomal protein S2 (9) . The mutant (YC81) had lost the ability to serve as an Hfr but still exerted entry exclusion when used as a recipient for mating. The kasugamycin resistance of this strain was transduced by P1 vir (6) to another Hfr strain, W1895 (a stable clone selected from Cavalli Hfr:PO2A, met). Thus, a kasugamycinresistant transductant designated as YC82 was obtained. The minimal inhibitory concentration values to kasugamycin of strains YC80, YC81, W1895, and YC82 are 320, 2,560, 80 and 160 ,ug/ml, respectively. Thus, the level of resistance was lower for this transductant than that for the original mutant. However, the strain YC82 was adopted for the present study because the molecular alteration of ribosomal protein S2 was observed also in this strain (9, unpublished data), and the possibility of multisite mutations as the consequence of mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine should have been decreased by transduction of the resistance marker into the strain W1895.
For mating, one volume of the Hfr culture at exponential growth phase was added to 9 volumes of the F-culture and incubated at 37 C for 75 min. Transduction was performed by the method of Lennox (8) using P1 vir (6) . The method of selecting kasugamycin-resistant transductants was the same as that used for streptomycin-resistant transductant in our previous report (12) . L broth, L agar, and L soft agar (10) were used in transduction and for growth of cells to prepare P1 vir lysates. Penassay broth (Difco) was used as an ordinary growth medium and for mating. Media for selection and scoring of the recombinants or transductants were either EMB-sugar agar or EM-sugar agar (5, 7) supplemented with appropriate nutritional requirements at 10,ug/ml. For phage sensitivity tests, EMB agar without added sugar was used. For scoring kasugamycin resistance, the drug was added at 50 ,ug/ml.
The mutagen, N-methyl-N'-nitro-Nnitroguanidine has been known to provoke multisite mutations at adjacent loci. As the original kasugamycin-resistant mutant from strain YC80 had been reverted to Lac+, it seemed likely that the kasugamycin locus might be located near the lac gene. Therefore, a mating of the kasugamycin-resistant transductant, strain YC82, with the F-strain JE346, which harbors several mutations near lac, was carried out. The markers lac+, ara+, purE+, and mtl+ were selected separately, with counterselection for met+. Recombinants were purified by successive single colony isolations and scored for unselected markers. The results obtained revealed a very close linkage of this kasugamycin resistance locus to purE (12 min on the Taylor and Trotter map [13] ). This was further con- strains YC82 and JE346 (F-, purE, tsx, lac, ara, mtl, strA, trp, gal), 93.3% of Pur+ transductants obtained were found to be resistant to kasugamycin. On the other hand, more than 90% of kasugamycin-resistant transductants obtained in the same cross were purine nonrequiring. These figures indicate that the responsible locus, ksgC, is located at 0.1 to 0.2 min from purE.
Thus, a newly recognized kasugamycin resistance locus, ksgC, was found near purE. Two other kasugamycin resistance loci were earlier reported. One of them, ksgA, is located at about 0.5 min (10) and is known to affect 16S RNA of 30S ribosome subunit (3, 4) . In KsgA mutants, two adjacent adenosine nucleotides in 16S RNA molecules which are known to be methylated in the wild type were found not to be methylated. The lack of a specific RNA methylase is the molecular basis of this mutation. Another kasugamycin resistance locus called ksgB was shown not to affect ribosomes. This mutation is at 25 to 39 min and is thought to be associated with an alteration in permeability to kasugamycin (11) .
It is interesting that this additional locus, ksgC, affects the ribosomal protein S2, but the location of this gene is distinct from the strA gene, where ribosomal mutations lie in a cluster.
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